Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02621840 · ClinicalTrials.gov registry record · NA

A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation

A NA study, sponsored by Wills Eye.

Completed
Registry status
NA
Development phase
442
Enrollment target

NCT02621840 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 442 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02621840, a NA study, has completed, sponsored by Wills Eye.

COMPLETED
Registry status
NA
Development phase
442 participants
Enrollment target

Study Summary

The investigators aim to investigate the impact of mandating on-site pre-admission testing on cataract cancellation rates in a randomized, prospective, intervention study. Cataract extraction is the most commonly performed ocular surgery making surgical training an integral component of ophthalmology residency. Patient cancellation of surgery results in a financial burden to the institution and a loss of essential educational experiences for the residents. An earlier study explored variables impacting cancellation rates and identified incomplete pre-admission testing as a major contributing factor to surgery cancellation. Patients will be randomized to either 1) the intervention group where on-site pre-admission testing will be mandated or 2) the control group, where on-site pre-admission testing will be offered but not mandated. Cancellation rates will be collected prospectively and statistical analysis utilized to evaluate the significance of intervention.

Interventions

  • BEHAVIORAL Mandatory On-Site Pre-Admission Testing

Trial Details

FieldValue
Enrollment Target 442 participants
Start Date 2015-01
Est. Completion 2015-12
Phase NA

Sponsor

Wills Eye

59 total trials

What the Registry Record Tells You About NCT02621840

The ClinicalTrials.gov registry entry for NCT02621840 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 442 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mandatory On-Site Pre-Admission Testing is the first listed.

NCT02621840 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02621840 about?

NCT02621840 is a clinical study titled "A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation". The investigators aim to investigate the impact of mandating on-site pre-admission testing on cataract cancellation rates in a randomized, prospective, intervention study. Cataract extraction is the most commonly performed ocular surgery making surgical training an integral component of ophthalmolog...

What is the current status of trial NCT02621840?

This trial is currently completed. It is a NA study. The enrollment target is 442 participants. The study started on 2015-01. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02621840?

The interventions under investigation include: Mandatory On-Site Pre-Admission Testing (BEHAVIORAL).

Who is sponsoring clinical trial NCT02621840?

This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.